These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 4649349)

  • 1. Effect of L-aromatic amino acid decarboxylase inhibition on metabolism of dihydroxyphenylalanine by isolated perfused rat liver.
    Tyce GM; Owen CA
    Biochem Pharmacol; 1972 Nov; 21(22):2977-89. PubMed ID: 4649349
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of peripheral aromatic L-amino acids decarboxylase inhibitor on L-(2- 14 C)-3,4-dihydroxyphenylalanine metabolism in man.
    Messiha FS; Hsu TH; Bianchine JR
    Biochem Pharmacol; 1972 Aug; 21(15):2144-7. PubMed ID: 4645885
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of 3,4-dihydroxyphenylalanine by isolated perfused rat liver.
    Tyce GM
    Biochem Pharmacol; 1971 Dec; 20(12):3447-62. PubMed ID: 5132891
    [No Abstract]   [Full Text] [Related]  

  • 4. Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa.
    Bianchine JR; Messiha FS; Hsu TH
    Clin Pharmacol Ther; 1972; 13(4):584-94. PubMed ID: 5042372
    [No Abstract]   [Full Text] [Related]  

  • 5. [Selective increase of C14-catecholamines in the brain due to peripheral inhibition of decarboxylase].
    Bartholini G; Pletscher A; Burkard WP
    Helv Physiol Pharmacol Acta; 1967; 25(2):CR170-2. PubMed ID: 5588156
    [No Abstract]   [Full Text] [Related]  

  • 6. Variations in aromatic amino acid decarboxylase activity towards DOPA and 5-hydroxytryptophan caused by pH changes and denaturation.
    Bender DA; Coulson WF
    J Neurochem; 1972 Dec; 19(12):2801-10. PubMed ID: 4652630
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation of metabolites of L-dopa--a possible source of error.
    Tyce GM; Sharpless NS; Owen CA
    Biochem Pharmacol; 1972 Sep; 21(17):2409-12. PubMed ID: 4647075
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of various decarboxylase inhibitors on the cerebral metabolism of dihydroxyphenylalanine.
    Bartholini G; Pletscher A
    J Pharm Pharmacol; 1969 May; 21(5):323-4. PubMed ID: 4390126
    [No Abstract]   [Full Text] [Related]  

  • 9. Decarboxylation of 3,4-dihydroxyphenylalanine by oxyhemoglobin.
    Yamabe H; Lovenberg W
    Biochem Biophys Res Commun; 1972 May; 47(4):733-9. PubMed ID: 5063594
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement of aromatic L-amino acid decarboxylase--a technical comment.
    Mackowiak ED; Hare TA; Vogel WH
    Biochem Med; 1972 Dec; 6(6):562-7. PubMed ID: 4640195
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of serotonin by the isolated perfused rat liver--effect of glucuronyl transferase deficiency or monoamine oxidase inhibition.
    Tyce GM; Flock EV; Owen CA
    Biochem Pharmacol; 1968 Aug; 17(8):1543-52. PubMed ID: 4386234
    [No Abstract]   [Full Text] [Related]  

  • 12. Cerebral accumulation and metabolism of C14-dopa after selective inhibition of peripheral decarboxylase.
    Bartholini G; Pletscher A
    J Pharmacol Exp Ther; 1968 May; 161(1):14-20. PubMed ID: 5648492
    [No Abstract]   [Full Text] [Related]  

  • 13. The influence of L-DOPA perfusion concentrations and peripheral decarboxylase inhibition on dopa accumulation and decarboxylation in isolated perfused rat brains.
    Horst WD; Bautz G; Renyi E; Spirt N
    Neuropharmacology; 1973 Dec; 12(12):1145-51. PubMed ID: 4782694
    [No Abstract]   [Full Text] [Related]  

  • 14. Increase of cerebral catecholamines caused by 3,4-dihydroxyphenylalanine after inhibition of peripheral decarboxylase.
    Bartholini G; Burkard WP; Pletscher A
    Nature; 1967 Aug; 215(5103):852-3. PubMed ID: 6049735
    [No Abstract]   [Full Text] [Related]  

  • 15. [Parkinsonism and plasma metabolism of dihydroxyphenylalanine administered with an inhibitor of decarboxylase].
    Geissbühler F; Constantinidis J; Eisenring JJ; Krassoievitch M; Yanniotis G; Tissot R
    Clin Chim Acta; 1971 Jun; 33(1):111-5. PubMed ID: 5097993
    [No Abstract]   [Full Text] [Related]  

  • 16. Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase.
    Carlsson A; Davis JN; Kehr W; Lindqvist M; Atack CV
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 275(2):153-68. PubMed ID: 4404948
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective rise in brain dopamine by inhibition of extracerebral levodopa decarboxylation.
    Pletscher A; Bartholini G
    Clin Pharmacol Ther; 1971; 12(2):344-52. PubMed ID: 5577483
    [No Abstract]   [Full Text] [Related]  

  • 18. Formation of monoamines from various amino acids in the brain after inhibition of extracerebral decarboxylase.
    Bartholini G; Constantinidis J; Tissot R; Pletscher A
    Biochem Pharmacol; 1971 Jun; 20(6):1243-7. PubMed ID: 5315769
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative investigation of inhibitors of extracerebral dopa decarboxylase in man and rats.
    Kuruma I; Bartholini G; Tissot R; Fletscher A
    J Pharm Pharmacol; 1972 Apr; 24(4):289-94. PubMed ID: 4402836
    [No Abstract]   [Full Text] [Related]  

  • 20. [Potentiation of the central effect of DOPA after selective inhibition of extracerebral decarboxylase].
    Gaillard JM; Schaeppi R; Tissot R
    Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):423-37. PubMed ID: 5348411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.